Unique ID issued by UMIN | UMIN000048309 |
---|---|
Receipt number | R000054616 |
Scientific Title | Observational study of the effect of aripiprazole on waking difficulty |
Date of disclosure of the study information | 2022/07/10 |
Last modified on | 2023/08/30 12:11:23 |
Observational study of the effect of aripiprazole on waking difficulty
Observational study of the effect of aripiprazole on waking difficulty
Observational study of the effect of aripiprazole on waking difficulty
Observational study of the effect of aripiprazole on waking difficulty
Japan |
Patient being treated for depression with difficulty waking up for which aripiprazole was prescribed
Psychiatry |
Others
NO
The purpose of this study is to examine the response of depressed patients receiving aripiprazole as a treatment to psychiatric symptoms and difficulty waking using objective measures.
Efficacy
Confirmatory
Pragmatic
Not applicable
Aripiprazole is administered for 28 days, and actigraph and PSG are performed before and after administration.
Actigraphic and PSG data will be investigated.
1,Japanese version of Karolinska. Sleepiness Scale:State of sleepiness
2,Visual Analog Scale: Difficulty falling asleep, awakening in the middle of the day, difficulty sleeping soundly, mood, evaluation of sleepiness
3,Epworth sleepiness Scale: Subfective sleep quality
4,the Japanese version of the Pittsburgh Sleep Quality Index: Subjective sleep quality severity
Observational
12 | years-old | <= |
60 | years-old | >= |
Male and Female
1. Patients who have been diagnosed with major depressive disorder by DSM-V (Diagnostic and Statistical Manual of Disorders) and being treated with antidepressants.
2. Willingness and ability to follow the procedures of this study, including response to wearing the actigraph and consent to information collection. (In the case of minors, consent will be obtained from parents and guardians.)
1. Patients witha history of serious psychosomatic disorders.
2. Patients with a history of suicidal ideation or attempts.
3. Patients taking aripiprazole with contraindications or precautions.
4. Pregnant women, patients who may become pregnant, patients who wish to become pregnant, and lactating patients.
5. Patients who are deemed incapable of consenting to research.
6. Patients who are otherwise classified as unfit by the attending physicians for the research.
12
1st name | Hayato |
Middle name | |
Last name | Ohshima |
Kurume University School of Medicine
Department of Neuropsychiatry
830-0011
67 Asahi mati, Kurume city, Fukuoka, Japan.
0942-31-7564
ohshima_hayato@med.kurume-u.ac.jp
1st name | Hayato |
Middle name | |
Last name | Ohshima |
Kurume University School of Medicine
Department of Neuropsychiatry
830-0011
67 Asahi mati, Kurume city, Fukuoka, Japan.
0942-31-7564
ohshima_hayato@med.kurume-u.ac.jp
Kurume University School of Medicine
Kurume University School of Medicine
Self funding
Clinical research in Kurume University
67 Asahi mati, Kurume city, Fukuoka, Japan.
0942-35-3311
i_rinri@kurume-u.ac.jp
NO
2022 | Year | 07 | Month | 10 | Day |
Unpublished
Completed
2020 | Year | 09 | Month | 02 | Day |
2020 | Year | 11 | Month | 24 | Day |
2020 | Year | 12 | Month | 01 | Day |
2023 | Year | 12 | Month | 31 | Day |
2024 | Year | 04 | Month | 30 | Day |
2024 | Year | 04 | Month | 30 | Day |
2024 | Year | 04 | Month | 30 | Day |
case series studies
2022 | Year | 07 | Month | 07 | Day |
2023 | Year | 08 | Month | 30 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054616